AU1310201A - Cdt6 can inhibit angiogenesis and tumor growth, and can induce or enhance the formation of structures containing collagen - Google Patents

Cdt6 can inhibit angiogenesis and tumor growth, and can induce or enhance the formation of structures containing collagen

Info

Publication number
AU1310201A
AU1310201A AU13102/01A AU1310201A AU1310201A AU 1310201 A AU1310201 A AU 1310201A AU 13102/01 A AU13102/01 A AU 13102/01A AU 1310201 A AU1310201 A AU 1310201A AU 1310201 A AU1310201 A AU 1310201A
Authority
AU
Australia
Prior art keywords
cdt6
induce
enhance
formation
tumor growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13102/01A
Inventor
Ronald Peek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke Nederlandse Akademie van Wetenschappen
Original Assignee
Koninklijke Nederlandse Akademie van Wetenschappen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Nederlandse Akademie van Wetenschappen filed Critical Koninklijke Nederlandse Akademie van Wetenschappen
Publication of AU1310201A publication Critical patent/AU1310201A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1891—Angiogenesic factors; Angiogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU13102/01A 1999-10-21 2000-10-19 Cdt6 can inhibit angiogenesis and tumor growth, and can induce or enhance the formation of structures containing collagen Abandoned AU1310201A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99203466 1999-10-21
EP99203466 1999-10-21
PCT/NL2000/000674 WO2001029085A2 (en) 1999-10-21 2000-10-19 Cdt6 can inhibit angiogenesis and tumor growth, and can induce or enhance the formation of structures containing collagen v

Publications (1)

Publication Number Publication Date
AU1310201A true AU1310201A (en) 2001-04-30

Family

ID=8240767

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13102/01A Abandoned AU1310201A (en) 1999-10-21 2000-10-19 Cdt6 can inhibit angiogenesis and tumor growth, and can induce or enhance the formation of structures containing collagen

Country Status (2)

Country Link
AU (1) AU1310201A (en)
WO (1) WO2001029085A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3284475B1 (en) * 2015-04-17 2023-11-01 The University of Tokyo Agent for prevention or treatment of corneal disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057435A (en) * 1997-09-19 2000-05-02 Genentech, Inc. Tie ligand homologues
AU2000399A (en) * 1997-12-19 1999-07-12 Regeneron Pharmaceuticals, Inc. Receptor tyrosine kinase, ar-1, is a regulator of angiogenesis

Also Published As

Publication number Publication date
WO2001029085A3 (en) 2002-01-31
WO2001029085A2 (en) 2001-04-26

Similar Documents

Publication Publication Date Title
AU2001249881A1 (en) Method of treating the heart
EP1097165A4 (en) Novel inhibitors of angiogenesis and tumor growth
AU1746600A (en) Reduction, elimination, or stimulation of hair growth
AU7373700A (en) Vascular closure
AU5146900A (en) System promoting atrial pacing
AU2607100A (en) Antisense modulation of map kinase kinase 6 expression
AU5032500A (en) Treatment of irregular ventricular contractions
EP1137805A4 (en) Methods of facilitating vascular growth
AU2460099A (en) Mesoporous materials and methods of making the same
AU5562999A (en) Methods of modulating of angiogenesis
AU3771000A (en) Method of promoting angiogenesis
ZA200206318B (en) Modulation of bone formation.
AU7876900A (en) Antisense modulation of fra-1 expression
HK1036019A1 (en) Treatment of cardiac hypertrophy.
AU4187200A (en) The use of domains of type iv collagen t inhibit angiogenesis an tumour growth
ZA200109206B (en) Preparation of substituted piperidin-4-ones.
AU4998100A (en) Methods of using percarboxylic acid or anions thereof and methods of making the same
AU2001287136A1 (en) Antisense modulation of glioma-associated oncogene-1 expression
AU1921100A (en) Antisense modulation of smad4 expression
AU5394300A (en) Tissue engineering
AU6769900A (en) Formation of nanometer-scale structures
AU1310201A (en) Cdt6 can inhibit angiogenesis and tumor growth, and can induce or enhance the formation of structures containing collagen
AU7563800A (en) Marsh-mallow and the marsh-mallow production technique
AU3910900A (en) Antisense modulation of sra expression
ZA200109120B (en) Use of Arylalkanoylpyridazines.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase